Tiziana Life Sciences plc announced the addition of James (Jim) Tripp, as Chief Operating Officer and Head of Global Clinical Operations. Mr. Tripp, who will be responsible for all operations, including global clinical development for the company, is not being appointed to the plc board. Mr. Tripp has over twenty years' experience in biopharmaceutical operations and has been involved in all phases of drug development from discovery through commercialization.

Before joining the company he was Director, Clinical Management at Novo Nordisk, A/S.